Current Neuro-Oncology
Volume
11 Number 9
30 September 2009
Home > Publications > Current Neuro-Oncology > Volume 11, Year 2009 > Number 9, 30 September
Blauwblomme T, Varlet P, Goodden JR, Cuny ML, Piana H, Roujeau T,
Dirocco F, Grill J, Kieffer V, Boddaert N, Sainte-Rose C, Puget
S.
Forniceal glioma in children.
Clinical article.
J
Neurosurg Pediatr. 2009 Sep;4(3):249-53. doi:
10.3171/2009.4.PEDS08472. PMID:
19772409. Observational study. ˍ
Ranger A, McDonald W, Bauman GS, Del Maestro R.
Effects
of surgical excision and radiation on medulloblastoma cell
invasiveness.
Can
J Neurol Sci. 2009 Sep;36(5):631-7. doi:
10.1017/s0317167100008155. PMID:
19831134. Laboratory investigation. ˍ
Roldán GB, Scott JN, McIntyre JB, Dharmawardene M, de
Robles PA, Magliocco AM, Yan ES, Parney IF, Forsyth PA, Cairncross
JG, Hamilton MG, Easaw JC.
Population-based
study of pseudoprogression after chemoradiotherapy in GBM.
Can
J Neurol Sci. 2009 Sep;36(5):617-22. doi:
10.1017/s0317167100008131. PMID:
19831132. Observational study. ˍ
Scheinemann K, Bartels U, Huang A, Hawkins C, Kulkarni AV, Bouffet
E, Tabori U.
Survival and functional
outcome of childhood spinal cord low-grade gliomas. Clinical
article.
J
Neurosurg Pediatr. 2009 Sep;4(3):254-61. doi:
10.3171/2009.4.PEDS08411. PMID:
19772410. Observational study. ˍ
Umesh S, Tandon A, Santosh V, Anandh B, Sampath S, Chandramouli
BA, Sastry Kolluri VR.
Clinical and
immunohistochemical prognostic factors in adult glioblastoma
patients.
Clin
Neuropathol. 2009 Sep-Oct;28(5):362-72. PMID:
19788052. Observational study. ˍ
McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD,
Quinones-Hinojosa A.
Association of
surgically acquired motor and language deficits on overall
survival after resection of glioblastoma multiforme.
Neurosurgery.
2009 Sep 1;65(3):463-9. doi:
10.1227/01.NEU.0000349763.42238.E9. PMID:
19687690. Observational study. ˍ
Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR,
Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.
Association
between MGMT promoter hypermethylation and p53 mutation in
glioblastoma.
Cancer
Invest. 2009 Sep 1;27(8):825-9. doi:
10.1080/07357900902783211. PMID:
19544111. Laboratory investigation.
ˍ
Beier CP, Schmid C, Gorlia T, Kleinletzenberger C, Beier D, Grauer
O, Steinbrecher A, Hirschmann B, Brawanski A, Dietmaier C,
Jauch-Worley T, Kölbl O, Pietsch T, Proescholdt M, Rümmele
P, Muigg A, Stockhammer G, Hegi M, Bogdahn U, Hau P.
RNOP-09:
pegylated liposomal doxorubicine and prolonged temozolomide in
addition to radiotherapy in newly diagnosed glioblastoma--a phase
II study.
BMC
Cancer. 2009 Sep 2;9:308. doi:
10.1186/1471-2407-9-308. PMID:
19725960. Interventional study. ˍ
Rudin CM, Hann CL, Laterra J, Yauch
RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B,
LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA.
Treatment
of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
N
Engl J Med. 2009
Sep 2;361(12):1173-8. doi:
10.1056/NEJMoa0902903. PMID:
19726761. Case report. ˍ
Yauch RL, Dijkgraaf GJ, Alicke B,
Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA,
Tang T, Bazan JF, Kan Z, Seshagiri S, Hann CL, Gould SE, Low JA,
Rudin CM, de Sauvage FJ.
Smoothened
mutation confers resistance to a Hedgehog pathway inhibitor in
medulloblastoma.
Science.
2009 Sep 2;326(5952):572-4. doi:
10.1126/science.1179386. PMID:
19726788. Laboratory investigation. ˍ
Frosini D, Ceravolo R, Rossi C, Pesaresi I, Cosottini M,
Bonuccelli U.
Bilateral thalamic glioma
presenting with parkinsonism.
Mov
Disord. 2009 Sep 4;24(14):2168-9. doi:
10.1002/mds.22761. PMID:
19735095. Case report. ˍ
Gadji M, Fortin D, Tsanaclis AM, Drouin R.
Is
the 1p/19q deletion a diagnostic marker of
oligodendrogliomas?
Cancer
Genet Cytogenet. 2009 Sep 6;194(1):12-22. doi:
10.1016/j.cancergencyto.2009.05.004. PMID:
19737649. Observational study. ˍ
Rogne SG, Konglund A, Meling TR, Scheie D, Johannesen TB, Rønning
P, Helseth E.
Intracranial tumor
surgery in patients >70 years of age: is clinical practice
worthwhile or futile?
Acta
Neurol Scand. 2009 Sep 8;120(5):288-94. doi:
10.1111/j.1600-0404.2009.01157.x. PMID:
19737154. Observational study. ˍ
Erratum in: Acta
Neurol Scand.
2009 Nov 13;120(6):453. ˍ
Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann
K, Rottenfusser A, Marosi C.
Neurocognitive
training in patients with high-grade glioma: a pilot study.
J
Neurooncol. 2009 Sep 10;97(1):109-15. doi:
10.1007/s11060-009-0006-2. PMID:
19763790. Interventional study. ˍ
*Pallud J, Duffau H, Razak RA, Barbarino-Monnier P, Capelle L,
Fontaine D, Frenay M, Guillet-May F, Mandonnet E, Taillandier
L.
Influence of pregnancy in the
behavior of diffuse gliomas: clinical cases of a French glioma
study group.
J
Neurol. 2009 Sep 10;256(12):2014-20. doi:
10.1007/s00415-009-5232-1. PMID:
19763385. Observational study. ˍ
Hayashi Y, Nakada M, Tanaka S, Uchiyama N, Hayashi Y, Kita D,
Hamada J.
Implication of
5-aminolevulinic acid fluorescence of the ventricular wall for
postoperative communicating hydrocephalus associated with
cerebrospinal fluid dissemination in patients with glioblastoma
multiforme: a report of 7 cases.
J
Neurosurg. 2009 Sep 11;112(5):1015-9. doi:
10.3171/2009.8.JNS09516. PMID:
19747042. Case report. ˍ
Prayson NF, Angelov L, Prayson RA.
Microscopic
thrombi in glioblastoma multiforme do not predict the development
of deep venous thrombosis.
Ann
Diagn Pathol. 2009 Sep 12;13(5):291-6. doi:
10.1016/j.anndiagpath.2009.05.002. PMID:
19751904. Observational study. ˍ
*Sonoda Y, Kumabe T, Nakamura T, Saito R, Kanamori M, Yamashita Y,
Suzuki H, Tominaga T.
Analysis of IDH1
and IDH2 mutations in Japanese glioma patients.
Cancer
Sci. 2009 Sep 14;100(10):1996-8. doi:
10.1111/j.1349-7006.2009.01270.x. PMID:
19765000. Laboratory investigation. ˍ
Casartelli G, Dorcaratto A, Ravetti JL, Sola S, Vitali A, Merlo
DF, Frosina G.
Survival of high grade
glioma patients depends on their age at diagnosis.
Cancer
Biol Ther. 2009 Sep 15;8(18):1719-21. doi:
10.4161/cbt.8.18.9209. PMID:
19633420. Observational study. ˍ
Nobusawa S, Watanabe T, Kleihues P, Ohgaki H.
IDH1
mutations as molecular signature and predictive factor of
secondary glioblastomas.
Clin
Cancer Res. 2009 Sep 15;15(19):6002-7. doi:
10.1158/1078-0432.CCR-09-0715. PMID:
19755387. Observational study. ˍ
Leal T, Robins HI.
Bevacizumab induced
reversible thrombocytopenia in a patient with recurrent high-grade
glioma: a case report.
Cancer
Chemother Pharmacol. 2009 Sep 16;65(2):399-401. doi:
10.1007/s00280-009-1118-2. PMID:
19756604. Case report. ˍ
*Halkett GK, Lobb EA, Oldham L, Nowak AK.
The
information and support needs of patients diagnosed with High
Grade Glioma.
Patient
Educ Couns. 2009 Sep 16;79(1):112-9. doi:
10.1016/j.pec.2009.08.013. PMID:
19762197. Observational study. ˍ
Hasegawa H, Pal D, Ramirez R, Ismail A, Marks P.
Glioblastoma
multiforme fades on CT imaging after dexamethasone therapy.
J
Clin Neurosci. 2009 Sep 17;16(12):1707-8. doi:
10.1016/j.jocn.2009.02.024. PMID:
19766006. Case report. ˍ
Rosenfeld A, Kletzel M, Duerst R, Jacobsohn D, Haut P, Weinstein
J, Rademaker A, Schaefer C, Evans L, Fouts M, Goldman S.
A
phase II prospective study of sequential myeloablative
chemotherapy with hematopoietic stem cell rescue for the treatment
of selected high risk and recurrent central nervous system
tumors.
J
Neurooncol. 2009 Sep 21;97(2):247-55. doi:
10.1007/s11060-009-0009-z. PMID:
19768658. Interventional study. ˍ
Blatt J, Deal AM, Mesibov G.
Autism in
children and adolescents with cancer.
Pediatr
Blood Cancer. 2009 Sep 22;54(1):144-7. doi:
10.1002/pbc.22303. PMID:
19774639. Observational study. ˍ
Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman
D, Buckner J, Fink K, Souhami L, Laperriere N, Mehta M, Curran W;
Radiation Therapy Oncology Group (RTOG); North Central Cancer
Treatment Group (NCCTG); Southwest Oncology Group (SWOG); National
Cancer Institute of Canada Clinical Trials Group (NCIC CTG);
Eastern Cooperative Oncology Group (ECOG).
Cognition
and quality of life after chemotherapy plus radiotherapy (RT) vs.
RT for pure and mixed anaplastic oligodendrogliomas: radiation
therapy oncology group trial 9402.
Int
J Radiat Oncol Biol Phys. 2009 Sep 23;77(3):662-9. doi:
10.1016/j.ijrobp.2009.06.004. PMID:
19783377. Interventional study. ˍ
Weber DC, Casanova N, Zilli T, Buchegger F, Rouzaud M, Nouet P,
Vees H, Ratib O, Dipasquale G, Miralbell R.
Recurrence
pattern after [(18)F]fluoroethyltyrosine-positron emission
tomography-guided radiotherapy for high-grade glioma: a
prospective study.
Radiother
Oncol. 2009 Sep 24;93(3):586-92. doi:
10.1016/j.radonc.2009.08.043. PMID:
19782417. Interventional study. ˍ
Pérez-Gómez JL, Rodríguez-Alvarez CA,
Marhx-Bracho A, Rueda-Franco F.
Stereotactic
biopsy for brainstem tumors in pediatric patients.
Childs
Nerv Syst. 2009 Sep 26;26(1):29-34. doi:
10.1007/s00381-009-1000-x. PMID:
19784659. Observational study. ˍ
Kang HC, Kim IH, Eom KY, Kim JH, Jung HW.
The
role of radiotherapy in the treatment of newly diagnosed
supratentorial low-grade oligodendrogliomas: comparative analysis
with immediate radiotherapy versus surgery alone.
Cancer
Res Treat. 2009 Sep 28;41(3):132-7. doi:
10.4143/crt.2009.41.3.132. PMID:
19809562. Observational study. ˍ
Taylor AJ, Frobisher C, Ellison DW, Reulen RC, Winter DL, Taylor
RE, Stiller CA, Lancashire ER, Tudor EC, Baggott C, May S, Hawkins
MM.
Survival after second primary
neoplasms of the brain or spinal cord in survivors of childhood
cancer: results from the British Childhood Cancer Survivor
Study.
J
Clin Oncol. 2009 Sep 28;27(34):5781-7. doi:
10.1200/JCO.2009.22.4386. PMID:
19786666. Observational study. ˍ
*Ghulam Muhammad AK, Candolfi M, King GD, Yagiz K, Foulad D,
Mineharu Y, Kroeger KM, Treuer KA, Nichols WS, Sanderson NS, Yang
J, Khayznikov M, Van Rooijen N, Lowenstein PR, Castro
MG.
Antiglioma immunological memory in
response to
conditional cytotoxic/immune-stimulatory gene therapy: humoral and
cellular immunity
lead to tumor regression.
Clin
Cancer Res. 2009 Sep 29;15(19):6113-27. doi:
10.1158/1078-0432.CCR-09-1087. PMID:
19789315. Laboratory investigation. ˍ
Razis E, Selviaridis P, Labropoulos S, Norris JL, Zhu MJ, Song DD,
Kalebic T, Torrens M, Kalogera-Fountzila A, Karkavelas G,
Karanastasi S, Fletcher JA, Fountzilas G.
Phase
II study of neoadjuvant imatinib in glioblastoma: evaluation
of clinical and molecular effects of
the treatment.
Clin
Cancer Res. 2009 Sep 29;15(19):6258-66. doi:
10.1158/1078-0432.CCR-08-1867. PMID:
19789313. Interventional study. ˍ